Epiduroscopic laser neural decompression for lumbar Failed Back Surgery Syndrome has an outcome profile that is difficult to find elsewhere in interventional pain management. Jo and Yang's foundational 2013 study documented 87% symptom relief at two weeks in a 77-patient cohort. Liawrungrueang and colleagues, writing in Neurospine in January 2025, reported 93.3% success with enhanced epiduroscopic technique in a prospective series. The ongoing RAPID Study (NCT05432219, 2025) is establishing the randomized controlled trial infrastructure that could define epiduroscopy-guided decompression as a standard of care designation for appropriately selected FBSS patients.

These numbers exist in a category where meaningful, durable relief is genuinely hard to achieve. FBSS — persistent or recurrent pain following technically successful lumbar spine surgery — affects an estimated 40% of lumbar surgical patients. The anterior epidural fibrosis that is the most common structural contributor to FBSS is invisible to CT and MRI. It cannot be characterized by any currently available preoperative or intraoperative imaging at the resolution required for targeted laser decompression. And it sits in a location — the anterior epidural space — that the instruments performing lumbar ELND today are not optimally designed to reach.

The 93.3% figure is not the ceiling. It is the current best approximation of what the procedure can achieve when performed by experienced operators with the best currently available instruments — instruments that are side-looking in a space that demands forward vision.

The anatomy of the problem: anterior epidural fibrosis and why current epiduroscopes do not see it directly

The epidural space in the lumbar spine is bounded anteriorly by the posterior longitudinal ligament and the posterior disc surfaces, and posteriorly by the ligamentum flavum and laminae. The thecal sac and its nerve roots occupy the central and posterior portions of the canal. Anterior epidural fibrosis — the pathological accumulation of dense fibrous tissue in the anterior epidural space following surgery, disc herniation, or inflammatory processes — compresses exiting nerve roots from the front, in a location that is anatomically separated from the posterior epidural approach by the thecal sac itself.

Current epiduroscopes are designed for posterior epidural access via the sacral hiatus. They are side-looking instruments: the lens faces laterally rather than forward. Navigating from a posterior approach to an anterior target with a side-looking lens requires a combination of fluoroscopic guidance, catheter manipulation under tactile feedback, and working knowledge of expected anatomy. In experienced hands, this combination delivers the 87–93% outcomes documented in the literature. What it cannot deliver is direct visualization of the anterior target — the fibrotic tissue itself — during navigation and laser delivery.

The proceduralist performing lumbar ELND today is navigating toward a target they can approximate but not directly see, delivering laser energy to a tissue they can infer but not confirm, guided by fluoroscopy that shows bone landmarks and approximate catheter position but nothing of the anterior epidural contents.

What the SFE changes in the lumbar ELND workflow

The Scanning Fiber Endoscope brings three capabilities to lumbar ELND that change the procedure from a navigation approximation into a tissue-confirmed intervention.

Forward-looking visualization of the anterior target

The SFE is built on a single scanning fiber architecture with a forward-looking lens. In the lumbar epidural approach, forward-looking means the catheter tip sees the anterior epidural space as it advances toward it — before the tip reaches the fibrotic target rather than when the lateral lens happens to be adjacent to it. The clinical consequence is categorical rather than incremental: the operator knows what they are approaching, can confirm that the catheter tip is aligned with the fibrotic tissue rather than the dural sac or normal epidural fat, and can make navigation decisions based on what is directly ahead rather than on anatomical inference.

In patients with dense, multilevel epidural fibrosis — the clinical profile most likely to present as FBSS, most likely to have had prior epiduroscopy attempts, and most likely to have distorted anatomy from prior surgical scarring — forward visualization is the difference between navigating a known territory and navigating an unknown one. Prior surgery changes where the fibrosis is, how extensive it is, and what adjacent structures look like. A lateral lens shows what is beside the catheter. A forward lens shows what the catheter is about to enter.

OCT tissue characterization at the target site

Optical coherence tomography at 15–25 µm axial resolution provides real-time cross-sectional tissue microstructure at the catheter tip. In the lumbar anterior epidural space, this capability enables four confirmations that no current epiduroscope can provide:

•       → Dense epidural fibrosis produces a characteristic high-backscatter, irregular OCT pattern that distinguishes it from normal epidural fat (low, homogeneous backscatter) and from the dural surface (high specular reflectance). The operator can confirm, at the tissue level, that the catheter tip is positioned against the therapeutic target before initiating laser delivery.  Fibrosis versus normal tissue

•       → OCT penetration of approximately 3 mm provides cross-sectional structure of the fibrotic layer — its thickness, its internal organization, whether it is superficial scar or deep organized fibrosis. This informs laser parameter selection: energy, pulse duration, and number of applications appropriate for the specific tissue architecture at the point of treatment.  Fibrosis depth and organization

•       → In dense fibrosis adjacent to the thecal sac, the proximity of the dural surface is the primary safety constraint for laser delivery. OCT identifies the dural surface in real time, enabling quantitative proximity assessment that fluoroscopy cannot provide and that tactile feedback alone cannot reliably detect in organized scar tissue.  Dural surface proximity

•       → Fluorescence imaging differentiates vascularized inflammatory tissue from avascular mature fibrosis. The Ho:YAG laser parameters appropriate for mature scar are different from those appropriate for inflamed, vascularized adhesion. This distinction, currently invisible to every epiduroscopic tool, directly governs safe and effective energy delivery selection at each treatment site.  Active inflammation versus mature scar

What this means for outcomes

The 6-point gain between the 2013 and 2025 lumbar ELND data — from 87% to 93.3% — was achieved with enhanced technique using instruments that are structurally unchanged in their fundamental limitation: they remain side-looking. A forward-looking scope with OCT tissue confirmation at the target site addresses the specific sources of outcome variance that enhanced technique cannot fully compensate for: navigation uncertainty in distorted anatomy, tissue-type ambiguity at the point of laser delivery, and dural proximity estimation in dense scar.

The clinical question the SFE program is designed to answer is not whether lumbar ELND works — the evidence is clear that it does. The question is what the outcome ceiling looks like when the visualization limitation is removed.

The patient population and commercial landscape

Lumbar ELND is performed at meaningful volume today. The FBSS patient population — broadly defined as patients with persistent or recurrent pain following lumbar surgery — numbers in the millions in the United States, with a procedurally addressable subset estimated in the hundreds of thousands annually. ELND penetration of this population remains low relative to the clinical opportunity, in part because of the procedure's dependence on specialized epiduroscopy infrastructure and in part because outcomes, while strong, have not been consistently reproduced across centers with varying experience.

The SFE platform is designed to change both constraints. Forward-looking visualization with OCT guidance reduces the procedure's dependence on operator experience in navigating unfamiliar anatomy — the tissue confirmation capability makes the procedure more reproducible across skill levels. And a more reproducible procedure with a better-characterized outcome ceiling is a more defensible clinical and commercial case for broader adoption.

VerAvanti's lumbar ELND program is the primary commercial launch indication for the SFE platform. We are actively engaging spine centers with existing epiduroscopy infrastructure for clinical partnerships and KOL engagement. If you perform lumbar ELND, manage FBSS patients, or lead a program where this indication is relevant to your practice, I would welcome a direct conversation.